Moreover acetylcholinesterase (AChE) inhibition may help in the treatment of Alzheimer’s disease (AD), as well as senile dementia, myasthenia gravis [13], Parkinson’s disease [14] and ataxia [15], due to the associated cholinergic deficit [12]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.